Document:

Purchaser:___________________

                             SUBSCRIPTION AGREEMENT

                  --------------------------------------------

                         TRINITY MEDICAL GROUP USA, INC.
                  --------------------------------------------

Trinity Medical Group USA, Inc.
55 Shaver Street, Suite 320
San Rafael, California 94901

Gentlemen:

         1.  Subscription.  The  undersigned  hereby  applies to  purchase  from
Trinity  Medical  Group USA,  Inc., a Florida  corporation  (the  "Company"),  a
convertible  promissory  note  issued  by  the  Company  to  the  order  of  the
undersigned  for the  principal  amount of $500,000,  substantially  in the form
attached hereto as Attachment A (the "Convertible  Note").  THIS SUBSCRIPTION IS
IRREVOCABLE,  BUT MAY BE REJECTED BY THE COMPANY IN ITS SOLE discretion.  In the
event that the  undersigned's  subscription  documents  are  returned to it, the
undersigned understands that all of its obligations hereunder shall terminate.

         2.  Representations  and  Warranties.   The  undersigned  acknowledges,
represents, warrants and agrees as follows:

            (a)  Authorization.  The  decision to invest and the  execution  and
delivery  of  this  agreement  by  the  undersigned,   the  performance  by  the
undersigned of its obligations hereunder and the consummation by the undersigned
of the transactions  contemplated  hereby have been duly authorized and no other
proceedings on the part of the  undersigned is necessary.  The person  executing
this agreement on behalf of the undersigned  has all right,  power and authority
to  execute  and  deliver  this  agreement  on behalf of the  undersigned.  This
agreement has been duly executed and delivered by the undersigned and,  assuming
the due  authorization,  execution  and  delivery  hereof by the  Company,  will
constitute  the  legal,  valid  and  binding  obligations  of  the  undersigned,
enforceable  against the undersigned in accordance with its terms, except as the
same  may be  limited  by  applicable  bankruptcy,  insolvency,  reorganization,
moratorium or other similar laws affecting the rights of creditors generally and
the availability of equitable remedies.

            (b)  Accredited   Investor.   The   undersigned  is  aware  of  what
constitutes  an Accredited  Investor as that term is defined under  Regulation D
promulgated under the Securities Act of 1933, as amended (the "Act"),  and under
the laws, if any, of each state governing the  undersigned,  and the undersigned
is an Accredited  Investor for purposes of Regulation D and the laws, if any, of
the  state  governing  the  undersigned.  The  undersigned  is able to bear  the
economic  risks of this  investment  and,  consequently,  without  limiting  the
generality of the

<PAGE>

foregoing,  is able to hold the Convertible  Note and the shares of Common Stock
issuable upon conversion of the Convertible  Note and the shares of Common Stock
issuable  upon  exercise  of the Warrant to be issued on the  conversion  of the
Convertible  Note  (the  "Shares")  for an  indefinite  period of time and has a
sufficient  net worth to sustain a loss of its entire  investment in the Company
in the event such loss should occur.

           In  addition,  the  undersigned  meets at least one of the  following
criteria (please check where applicable):

         (A)      A natural  person and has,  or with his or her spouse  jointly
                  has,  and the  undersigned  and his or her spouse will have at
                  the time of purchase of the Shares,  a net worth (i.e.,  total
                  assets  in  excess   of  total   liabilities)   in  excess  of
                  $1,000,000;

         (B)      A  natural  person  and has had an  individual  annual  income
                  (exclusive  of his  or  her  spouse's  income,  regardless  of
                  whether this is a joint investment with such spouse) in excess
                  of  $200,000  in each of the two  most  recent  years or joint
                  income with his or her spouse in excess of $300,000 in each of
                  those years, and the undersigned has a reasonable  expectation
                  of reaching  the same income  level in the current  year.  For
                  this  purpose,   a  person's  income  is  the  amount  of  his
                  individual  adjusted  gross  income (as  reported on a federal
                  income tax return),  increased by the following  amounts:  (a)
                  any  deduction  for  depletion  (Section  611 et  seq.  of the
                  Internal  Revenue  --  ---  Code  of  1986,  as  amended  (the
                  "Code")), (b) any deduction for a portion of long-term capital
                  gains  (Section  1202  of the  Code),  (c) any  exclusion  for
                  interest on tax exempt municipal  obligations  (Section 103 of
                  the  Code);  and (c) any  losses of a  partnership  or limited
                  liability  company allocated to the individual (as reported on
                  Schedule E of Form 1040);

         (C)      A bank as defined in Section 3(a)(2) of the Act or any savings
                  and  loan  association  or other  institution  as  defined  in
                  Section 3(a)(5)(A) of the Act, whether acting in an individual
                  or fiduciary capacity;

         (D)      A broker  or  dealer  registered  pursuant  to the  Securities
                  Exchange Act of 1934;

         (E)      An insurance company as defined in Section 2(13) of the Act;

         (F)      An investment  company registered under the Investment Company
                  Act of 1940 (the "1940 Act");

         (G)      A business  development company as defined in Section 2(a)(48)
                  of the 1940 Act;

         (H)      A Small Business Investment Company licensed by the U.S. Small
                  Business  Administration  under  Section  301(c) or (d) of the
                  Small Business Investment Act of 1958;

         (I)      An employee  benefit plan within the meaning of Title I of the
                  Employment  Retirement  Income Security Act of 1974 ("ERISA"),
                  and either (i) the  investment

                                      -2-
<PAGE>

                  decision with respect to this  subscription is to be made by a
                  plan fiduciary, as defined in Section 3(21) of ERISA, which is
                  either a bank,  savings  and loan  association,  an  insurance
                  company,  or a  registered  investment  adviser,  or (ii)  the
                  employee benefit plan has total assets in excess of $5,000,000
                  or (iii) if a  self-directed  plan,  investment  decisions are
                  made solely by Accredited Investors;

         (J)      A private business  development  company as defined in Section
                  202(a)(22) of the Investment Advisers Act of 1940;

         (K)      A  corporation,  Massachusetts  or similar  business  trust, a
                  partnership or an organization  described in Section 501(c)(3)
                  of the  Internal  Revenue  Code,  not formed for the  specific
                  purpose of acquiring  the Shares,  with total assets in excess
                  of $5,000,000;

         (L)      A trust, with total assets in excess of $5,000,000, not formed
                  for the specific purpose of acquiring the Convertible Note and
                  the Shares,  which  acquisition is directed by a sophisticated
                  person as  described  in Rule  506(b)(2)(ii)  of  Regulation D
                  promulgated under the Act; or

         (M)      An  entity  in  which  all of the  equity  owners  qualify  as
                  "Accredited Investors."

            (c)  Evaluation of Risks.  The  undersigned  has such  knowledge and
experience in financial and business  matters as to be capable of evaluating the
merits and risks of, and bearing the economic  risks  entailed by, an investment
in the  Company  and  of  protecting  its  interests  in  connection  with  this
transaction.  The  undersigned  recognizes  that its  investment  in the Company
involves  a high  degree of risk and that the  Company  is  dependent  upon this
private placement to continue its operations.

            (d)  High  Degree  of Risk.  The  undersigned  acknowledges  that an
investment in the  Convertible  Note and the Shares is a speculative  investment
and  involves a high degree of risk,  and that the Company  makes no  assurances
whatever  concerning the present or prospective value of the Convertible Note or
the Shares.  The undersigned  understands that the price of the Convertible Note
has been arbitrarily  determined by the Company and bears no relationship to its
assets, earnings, book value or other accepted criteria of value.

            (e) Due  Diligence.  The  undersigned  has  received  a copy of such
documents relating to the Company as requested by the undersigned (collectively,
the "Documents"), has carefully reviewed such Documents, has had the opportunity
to obtain any  additional  information  necessary  to verify the accuracy of the
information  contained in such  Documents and has been given the  opportunity to
meet with  representatives  of the Company and to have them answer any questions
and provide any  additional  information  regarding the terms and  conditions of
this  particular  investment  deemed relevant by the  undersigned,  and all such
questions  have  been  answered  and  requested   information  provided  to  the
undersigned's  full  satisfaction.  In  making  its  decision  to  purchase  the
Convertible  Note and the Shares,  the  undersigned  has relied  solely upon its
review of the  Documents  referred  to above,  this  agreement  and  independent
investigations made by it or its representatives.

                                      -3-
<PAGE>

            (f) Independent  Counsel.  The undersigned  acknowledges that it has
been advised to consult with its own attorney regarding legal matters concerning
the Company and to consult with its tax advisor  regarding the tax  consequences
of acquiring the Convertible  Note and the Shares.  Parker Chapin LLP is counsel
to the Company in the transactions contemplated hereby and herein.

            (g) No  Distribution.  The  undersigned is acquiring the Convertible
Note and the Shares for its own account for investment and not with a view to or
for resale in connection with any distribution of the Shares. It has not offered
or sold any  portion  of the  Convertible  Note or the Shares and has no present
intention  of  dividing  the  Convertible  Note or the Shares  with others or of
selling,  distributing or otherwise  disposing of any portion of the Convertible
Note or the  Shares  either  currently  or  after  the  passage  of a  fixed  or
determinable  period of time or upon the  occurrence  or  non-occurrence  of any
predetermined event or circumstance.

            (h) No  Registration.  The undersigned  understands that the sale of
the Shares has not been  registered  under the Act in reliance upon an exemption
therefrom for non-public or limited offerings.  The undersigned understands that
the Shares must be held  indefinitely  unless the sale or other transfer thereof
is subsequently  registered under the Act or an exemption from such registration
is available at that time.

            (i)  Registration  Rights.  The  undersigned  shall have  piggy-back
registration rights with respect to the Shares then held by the undersigned. The
Company  agrees to file a  registration  statement to register the Shares within
thirty  (30) days after the date the  Company  accepts  this  subscription  (the
"Closing  Date").  The Company shall respond to comments of the  Securities  and
Exchange  Commission  ("SEC")  within five (5) business  days of receipt of said
comments  and will use its  reasonable  best  efforts to cause the  registration
statement to be declared  effective by the SEC within  ninety (90) days from the
Closing Date.  The Company shall keep the  registration  statement  continuously
effective  through November 19, 2001, and shall cause the related  prospectus to
be amended or supplemented by a required prospectus  supplement pursuant to Rule
424 under the Securities Act of 1933, as amended. If the registration  statement
is not filed  within 30 days of the issuance of the  Convertible  Note or if the
registration  statement  is not  declared  effective  with respect to the Shares
within 120 days of the issuance of the Convertible Note (each such failure being
referred to as an "Event"), the Maker shall pay as liquidated damages and not as
a  penalty  to the  Holder an amount  equal to 2% of the  purchase  price of the
Convertible  Note for each 30-day  period  until the  applicable  Event has been
cured.  The amount of the liquidated  damages shall be prorated on a daily basis
for periods less than 30 days. The liquidated  damages shall be paid within five
(5)  business  days of the end of each month during which the Event has occurred
and is continuing.

            (j) Additional Transfer  Restrictions.  The undersigned  understands
and agrees that, in addition to the  restrictions  set forth in this  agreement,
the following restrictions and limitations are applicable to its purchase of the
Convertible Note and any resales, pledges,  hypothecations or other transfers of
the Shares:

                                      -4-
<PAGE>

            (i) The following legend reflecting all applicable restrictions will
be placed on any certificate(s) or other document(s)  evidencing the Warrants or
the Shares and the  undersigned  must comply with the terms and  conditions  set
forth in such legends  prior to any resales,  pledges,  hypothecations  or other
transfers of the Shares:

         "THE  SECURITIES   REPRESENTED  BY  THIS   CERTIFICATE  HAVE  NOT  BEEN
         REGISTERED  AND  MAY NOT BE  TRANSFERRED  UNLESS  (A)  THE  SHAREHOLDER
         WISHING TO  TRANSFER  SUCH  SECURITIES  PROVIDES  AN OPINION OF COUNSEL
         REASONABLY  CONCURRED IN BY COUNSEL FOR TRINITY MEDICAL GROUP USA, INC.
         (THE  "COMPANY")  STATING THAT THE PROPOSED  TRANSFER OF THE  COMPANY'S
         SECURITIES IS EXEMPT FROM THE REGISTRATION PROVISIONS OF ALL APPLICABLE
         FEDERAL AND STATE LAWS;  OR (B) SAID  SECURITIES  HAVE BEEN  REGISTERED
         PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED."

                  (ii) Stop transfer instructions have been or will be placed on
         any  certificates  or other  documents  evidencing  the Warrants or the
         Shares so as to restrict  the resale,  pledge,  hypothecation  or other
         transfer thereof in accordance with the provisions hereof.

         (k) No  Advertisements.  The  undersigned  is not  subscribing  for the
Convertible   Note  or  the  Shares  as  a  result  of  or   subsequent  to  any
advertisement,   article,   notice  or  other  communication  published  in  any
newspaper,  magazine, or similar media or broadcast over television or radio, or
presented at any seminar or meeting.

         (l) Capacity. The undersigned, if an individual, has reached the age of
majority in the state in which the  undersigned  resides,  has adequate means of
providing for the undersigned's  current financial needs and  contingencies,  is
able to bear the substantial  economic risks of an investment in the Convertible
Note and the Shares for an indefinite  period of time, has no need for liquidity
in such  investment,  and, at the present time,  could afford a complete loss of
such investment.

         (m) Indemnity.  The  undersigned  shall indemnify and hold harmless the
Company and each officer,  director or control person of the Company,  who is or
may be a party or is or may be threatened to be made a party to any  threatened,
pending or  completed  action,  suit or  proceeding,  whether  civil,  criminal,
administrative  or  investigative,  by reason of or  arising  from any actual or
alleged  misrepresentation  or misstatement of facts or omission to represent or
state facts made or alleged to have been made by the undersigned to the Company,
or omitted or alleged to have been omitted by the  undersigned,  concerning  the
undersigned, or its authority to invest or financial position in connection with
the offering or sale of the Convertible Note or the Shares,  including,  without
limitation,  any such  misrepresentation,  misstatement  or  omission  contained
herein or any other  document  submitted  by the  undersigned,  against  losses,
liabilities  and  expenses for which the  Company,  or any officer,  director or
control  person of the  Company has not  otherwise  been  reimbursed  (including
attorneys' fees,  judgments,  fines and amounts paid in settlement) actually and
reasonably  incurred by the Company or such officer,  director or control person
in connection  with such action,  suit or  proceeding.  In connection  with this

                                      -5-
<PAGE>

indemnity,  the  undersigned  represents  that all of the  information  provided
herein by the undersigned is true, complete and correct in all respects.

         (n)  Legends.  The  undersigned  acknowledges  that it has reviewed the
following legends:

         PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE
CONSIDERED  ONLY BY  PERSONS  WHO CAN  AFFORD TO  SUSTAIN A TOTAL  LOSS OF THEIR
INVESTMENT.

         THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED FOR SALE TO THE
PUBLIC UNDER THE  SECURITIES  ACT OF 1933, AS AMENDED (THE "ACT"),  OR ANY OTHER
SECURITIES LAWS, AND WILL BE OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE
REGISTRATION REQUIREMENTS OF SUCH LAWS. CONSEQUENTLY,  THE SECURITIES MAY NOT BE
OFFERED,  SOLD, OR OTHERWISE TRANSFERRED OR DELIVERED BY ANY INVESTOR EXCEPT, IN
THE  OPINION OF COUNSEL  FOR OR  SATISFACTORY  TO THE  COMPANY,  PURSUANT  TO AN
EXEMPTION FROM THE  REGISTRATION  REQUIREMENTS OF THE ACT AND IN ACCORDANCE WITH
APPLICABLE   STATE  OR  OTHER  SECURITIES  LAWS.  THE  SECURITIES  WILL  BEAR  A
RESTRICTIVE  LEGEND TO THE  FOREGOING  EFFECT,  AND EACH  INVESTOR  MUST SIGN AN
INVESTMENT REPRESENTATION CONSISTENT WITH THE FOREGOING.

         THERE IS  CURRENTLY NO PUBLIC OR OTHER  MARKET FOR THE  SECURITIES  AND
THERE CAN BE NO ASSURANCE THAT A PUBLIC OR OTHER MARKET WILL DEVELOP.  INVESTORS
SHOULD BE AWARE THAT THEY WILL BE  REQUIRED  TO BEAR THE  FINANCIAL  RISK OF THE
INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

         IN  MAKING  AN  INVESTMENT  DECISION  INVESTORS  MUST RELY ON THEIR OWN
EXAMINATION  OF THE ISSUER AND THE TERMS OF THE  OFFERING,  INCLUDING THE MERITS
AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR
STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY.  FURTHERMORE, THE FOREGOING
AUTHORITIES  HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED  THE ADEQUACY OF THIS
DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

         (o) Residence. The undersigned (check below if applicable):

|_|      is not a  "U.S.  person,"  as such  term is  defined  in  Regulation  S
         promulgated under the Act.

|_|      is not acquiring the Shares for the account of any U.S. person.

                                      -6-
<PAGE>

Purchaser           Co-Owner
---------           --------

  |_|                 |_|   (i)     I am a United States  citizen or resident of
                                    the  United  States for  federal  income tax
                                    purposes.

  |_|                 |_|   (ii)    I am neither a United  States  citizen nor a
                                    resident  of the  United  States  for United
                                    States federal income tax purposes.

         3.  ALL  INFORMATION  CONTAINED  IN  THIS  AGREEMENT  WILL  BE  TREATED
CONFIDENTIALLY.  However,  the  undersigned  agrees that the Company may present
this  agreement to such parties as the Company deems  appropriate if called upon
to establish  that the proposed offer and sale of the  Convertible  Note and the
Shares is exempt from  registration  under the Act or meets the  requirements of
applicable state securities law.

         4. The undersigned will notify the Company  immediately of any material
change in any  representation  made or any statement made in this agreement that
occurs  prior  to  the  closing  of  the  sale  of  the  Convertible  Note.  The
representations,  warranties and covenants of the undersigned  shall survive the
closing of the sale of the  Convertible  Note. The  undersigned  understands and
acknowledges that the Company is relying upon such information  provided in this
agreement to determine  that the exemption from the  registration  provisions of
the Act for  non-public  offerings  is  applicable  to the offer and sale of the
Convertible Note.

         5.  Subscription and Method of Payment.  (a) The undersigned  shall (i)
deliver to Parker Chapin LLP, The Chrysler  Building,  405 Lexington Avenue, New
York, New York 10174,  Attn:  Christopher  S. Auguste the executed  agreement by
overnight  courier or facsimile  (with original to follow by overnight  courier)
and  (ii)  deliver  to the  Company  the  amount  set  forth  on page 11 of this
agreement as the purchase price for the Convertible Note (the "Purchase  Price")
by check  payable to the Company or by wire  transfer of  immediately  available
funds to the account specified by the Company.

            (b) Promptly upon receipt of the funds and documents  required so to
be delivered and upon  acceptance by the Company of the  undersigned's  offer to
subscribe for the shares,  the Company shall deliver the Convertible Note to the
undersigned  registered in the name of the  undersigned  (or, if the undersigned
shall have a nominee,  registered in the name of such  nominee).  If the Company
does not accept the  undersigned's  offer to subscribe for the Convertible Note,
the Company shall return the Purchase Price to the undersigned without interest.

         6.  The  undersigned  shall  not,   directly  or  indirectly,   whether
voluntarily,  by  operation  of law,  upon  death or  otherwise,  sell,  pledge,
mortgage,  hypothecate,  give, bequeath, transfer, create a security interest in
or lien on,  place in trust  (voting or  otherwise),  assign or in any other way
whatsoever  encumber or dispose of, any of the Shares (or any interest therein),
or the stock certificate or certificates representing Shares.

                                      -7-
<PAGE>

         7. Miscellaneous.

            (a) The undersigned agrees not to transfer or assign this agreement,
the Convertible Note or the Shares or any of the undersigned's  interest herein,
and  further  agrees that the  transfer or  assignment  of this  agreement,  the
Convertible  Note or the Shares shall be made only upon  approval of the Company
and in accordance with all applicable laws.

            (b) This  agreement  constitutes  the entire  agreement  between the
undersigned  and the Company with  respect to the subject  matter  hereof.  This
agreement may be amended only by a writing executed by both of them.

            (c) This  agreement  shall be enforced,  and construed in accordance
with the laws of the State of New York,  without  regard  to the  principles  of
conflicts  of  laws  thereof.  Each of the  parties  hereto  hereby  irrevocably
consents and submits to the exclusive jurisdiction of the United States District
Court for the Southern  District of New York in connection  with any  proceeding
arising out of or relating to this  agreement or the  transactions  contemplated
hereby,  waives any objection to venue in such District (unless such court lacks
jurisdiction with respect to such proceeding, in which case, each of the parties
hereto  irrevocably  consents to the  jurisdiction of the courts of the State of
New York in connection with such proceeding and waives any objection to venue in
New York  County,  State of New York),  and agrees that  service of any summons,
complaint,  notice or other process  relating to such proceeding may be effected
in the manner  provided by clause (d) of this  paragraph  7. All of the fees and
expenses  of such  proceeding,  together  with  all  reasonable  attorney's  and
accountant's  fees and  expenses of each party hereto in  connection  therewith,
shall be borne by the losing party or parties, or as allocated by the court.

            (d) Any  notice,  demand,  request or other  communication  which is
required,  called for or  contemplated  to be given or made hereunder to or upon
any  party  hereto  shall be  deemed  to have  been  duly  given or made for all
purposes if (a) in writing and sent by (i)  messenger  or an  overnight  courier
service for next day  delivery  with  receipt  therefor,  or (ii)  certified  or
registered  mail,  postage  paid,  return  receipt  requested,  or (b)  sent  by
telegram,  facsimile  transmission or similar  electronic  means, with a written
copy  thereof  sent on the same day by postage paid  first-class  mail,  to such
party at the following address:

                    To the undersigned at:

                           RoyCap Inc.
                           4100 Yonge Street
                           Suite 504
                           Toronto, Ontario M2P 2G2
                           Attn:  Stephen Rider
                           Telecopier No.: (416) 221-1253

                                      -8-
<PAGE>

                    with a copy to:

                           Fogler Rubinoff LLP
                           77 King Street West
                           Suite 4400
                           Toronto, Ontario M5K 1G8
                           Attention:  Michael Slan
                           Telecopier No.: (416) 941-8852

                    To the Company at:

                           Trinity Medical Group USA, Inc.
                           55 Shaver Street, Suite 320
                           San Rafael, California 94901
                           Attention: Mr. James Namnath, Chief Executive Officer
                           Telecopier No.:  (415) 256-1944

                    with a copy to:

                           Parker Chapin LLP
                           The Chrysler Building
                           405 Lexington Avenue
                           New York, New York  10174
                           Attention:  Christopher S. Auguste
                           Telecopier No.:  (212) 704-6288

or such other  address as either party  hereto may at any time,  or from time to
time, direct by notice given to the other party in accordance with this section.
The date of giving or making of any such notice or demand  shall be, in the case
of clause (a)(i), the date of the receipt;  in the case of clause (a)(ii),  five
(5)  business  days after  such  notice or demand is sent;  and,  in the case of
clause (b), the business  day next  following  the date such notice or demand is
sent.

            (e) This  agreement  may be executed in  counterparts.  In the event
that any  provision  of this  agreement  becomes  or is  declared  by a court of
competent  jurisdiction  to be illegal,  unenforceable  or void,  this agreement
shall continue in full force and effect without said provision.

            (f)  Except as  otherwise  provided  herein,  no  amendment  of this
agreement  shall be valid or  effective,  unless in writing and signing by or on
behalf of the parties hereto.

            (g) No course of dealing or  omission or delay on the part of either
party hereto in asserting or exercising any right hereunder shall  constitute or
operate as a waiver of any such right.  No waiver of any provision  hereof shall
be  effective,  unless in writing  and signed by or on behalf of the party to be
charged  therewith.  No waiver shall be deemed a continuing  waiver or waiver in
respect of any other or subsequent breach or default, unless expressly so stated
in writing.

                                      -9-
<PAGE>

            (h) The  provisions  hereof are  severable and in the event that any
provision of this agreement  shall be determined to be invalid or  unenforceable
in any respect by a court of competent  jurisdiction,  the remaining  provisions
hereof  shall not be  affected,  but shall,  subject to the  discretion  of such
court,  remain in full  force  and  effect,  and any  invalid  or  unenforceable
provision  shall be deemed,  without  further  action on the part of the parties
hereto, amended and limited to the extent necessary to render the same valid and
enforceable.

            (i) Each party  hereto  covenants  and agrees  promptly  to execute,
deliver,  file or record such  agreements,  instruments,  certificates and other
documents  and to perform  such other and further acts as the other party hereto
may reasonably  request or as may otherwise be necessary or proper to consummate
and perfect the transactions contemplated hereby.

            (j)  This  agreement,   and  each  right,  interest  and  obligation
hereunder,  may not be assigned by either party hereto without the prior written
consent of the other party  hereto,  and any purported  assignment  without such
consent shall be void and without effect.

            (k) The section and other  headings  contained in this agreement are
for  convenience of reference only and do not in any way define or interpret the
intent of the  parties  or  modify or  otherwise  affect  any of the  provisions
hereof.

                                      -10-
<PAGE>

                             SUBSCRIBER INFORMATION

         Please  print here the exact name in which the  investor  desires go to
have the Shares registered (must be beneficial owner).

                                  RoyCap, Inc.
                 -----------------------------------------------

                    All correspondence relating to the undersigned's  investment
should be sent (check one):

         |X|      (i) to  the  address  of  the  undersigned  set  forth  on the
                  signature page hereof

         |_|      (ii) to the following address:

                    ---------------------------------------------------------

                    ---------------------------------------------------------

                    ---------------------------------------------------------

                    The  undersigned  may  be  contacted  by  telephone  at  the
following telephone number(s):

                    (i)    Home Telephone        ( - )_______________________

                    (ii)   Business Telephone    (416) 226-9921

         Amount of Convertible Note:             $ 500,000
                                                 -----------------------

                                      -11-
<PAGE>

                                 SIGNATURE PAGE
                                 --------------

                             FOR CORPORATE INVESTORS
                             -----------------------

         The  undersigned,  by executing this signature page,  hereby swears to,
adopts and  agrees to all terms,  conditions,  representations,  warranties  and
covenants contained in this Subscription  Agreement of which this signature page
is a part.

Note:  The officer authorized to bind the corporation must sign.

                                  RoyCap, Inc.
------------------------------------------------------------------------------
Name of Corporation (please print or type)

By: /s/ Stephen Rider
   ---------------------------------------------------------------------------

         (Signature of authorized agent)
------------------------------------------------------------------------------
Taxpayer Identification Number

Title: President
      -------------------------------------------------------------------------

         Address of Principal

         Corporate Offices:        4100 Yonge St.
                                   ---------------------------------------------
                                   Suite 504
                                   ---------------------------------------------
                                   Toronto, ONT. CANADA  M2P 2G2
                                   ---------------------------------------------

         Mailing Address, if different:
                                   ---------------------------------------------

                                   ---------------------------------------------

                                   ---------------------------------------------

State of Incorporation: Ontario, CANADA
                       ---------------------------------------------------------

Executed at Toronto, Ontario this 19th day of October, 2000.

                    City                         State

SUBSCRIPTION ACCEPTED:

TRINITY MEDICAL GROUP USA, INC.

By:/s/ James Namnath, CEO
   -----------------------------
      Name:
      Title:

Date:October 19, 2000
     ----------------

                                      -12-THIS NOTE HAS NOT BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE  "ACT"),  OR  APPLICABLE  STATE  SECURITIES  LAWS,  AND  MAY  NOT BE  SOLD,
TRANSFERRED,  PLEDGED OR  HYPOTHECATED  IN THE ABSENCE OF SUCH  REGISTRATION  OR
RECEIPT  BY THE  COMPANY  OF AN  OPINION  OF  COUNSEL  (WHICH  COUNSEL  SHALL BE
REASONABLY  ACCEPTABLE  TO  THE  COMPANY)  IN  THE  FORM,  SUBSTANCE  AND  SCOPE
REASONABLY  SATISFACTORY TO THE COMPANY THAT THIS NOTE MAY BE SOLD, TRANSFERRED,
HYPOTHECATED  OR OTHERWISE  DISPOSED OF,  UNDER AN EXEMPTION  FROM  REGISTRATION
UNDER THE ACT AND SUCH STATE SECURITIES LAWS.

                           CONVERTIBLE PROMISSORY NOTE

$500,000                                                       October 19, 2000

                  For value received, the undersigned, TRINITY MEDICAL GROUP
USA, INC., a Florida corporation (the "Maker"), hereby unconditionally promises
to pay to the order of ROYCAP INC., a corporation organized under the laws of
Ontario, Canada (the "Holder"), at such place as the Holder may designate, the
principal sum of FIVE HUNDRED THOUSAND DOLLARS ($500,000) on the Maturity Date
(as such term is hereinafter defined), and to pay interest on the unpaid
principal amount of this Note, commencing from the date hereof, before and after
the Maturity Date and after any judgment until paid in full, at the rate of
eight percent (8%) per annum (computed on the basis of a year of 360 days for
the actual number of days elapsed) until paid in full, in accordance with this
Note. All payments hereunder shall be in lawful money of the United States and
in immediately available funds.

                  1. Interest. Interest on the outstanding principal amount
under this Note shall accrue, in arrears, at the rate set forth herein,
commencing from the date hereof and continuing until the earlier of (i) the
conversion of this Note in accordance with Section 7 hereof and (ii) the payment
in full of the outstanding principal amount of this Note. Accrued interest shall
be due and payable semi-annually, commencing on April 19, 2001 in cash or, at
the option of the Maker, converted into shares of the Maker's common stock, par
value $.001 per share (the "Common Stock") at the conversion price set forth in
Section 7 hereof. Upon the occurrence of an Event of Default (as such term is
hereinafter defined) under this Note, then to the extent permitted by applicable
law, interest shall accrue on the outstanding principal amount hereof from the
date of such Event of Default until payment in full at the rate of ten percent
(10%) per annum (calculated as aforesaid) and shall be payable on demand. In no
instance shall the interest on this Note exceed the maximum amount permitted by
applicable law.

                  2. Payment of Principal. At the Maturity Date, the outstanding
principal amount of this Note plus all accrued and unpaid interest herein shall
be due and payable in cash or, at the option of the Holder, converted into the
Maker's Common Stock at the conversion price per share of Common Stock set forth
in Section 7 hereof. Upon the conversion of this Note as

<PAGE>

provided in Section 7(a) hereof, the outstanding principal amount of this Note,
together with accrued interest hereon, shall be deemed to be the consideration
for the Holder's interest in the Common Stock on the Maturity Date. For purposes
of this Note, the term "Maturity Date" shall mean the earlier of (i) October 19,
2001; or (ii) the date on which the Note becomes immediately due and payable
pursuant to Section 6 hereof.

                  3. Warrant. On the date of conversion, the Maker shall have
issued to the Holder a warrant, substantially in the form attached hereto as
Attachment A (the "Warrant") to purchase such number of shares of the Maker's
Common Stock equal to aggregate number of shares of Common Stock issued upon
conversion of this Note. The Warrant shall have an exercise price equal to $4.00
per share of the Common Stock and shall have a term of five (5) years from its
date of issuance.

                  4. Covenants.

                     (a) The Maker covenants to register for resale by the
Holder 450,000 shares of Common Stock being an estimate of the number of shares
of Common Stock issuable upon conversion of this Note and upon exercise of the
Warrant on a registration statement (the "Registration Statement") which shall
be filed by the Maker with the Securities and Exchange Commission ("SEC") within
thirty (30) days of the date hereof. The Maker shall respond to all SEC comments
within five (5) business days of receipt of the SEC's comments and will use its
reasonable best efforts to cause the Registration Statement to be declared
effective by the SEC within ninety (90) days of the date hereof.

                     (b) The Maker shall keep the Registration Statement
continuously effective through November 19, 2001, and shall cause the related
prospectus to be amended or supplemented by a required prospectus supplement
pursuant to Rule 424 under the Securities Act of 1933, as amended. If the
Registration Statement is not filed within 30 days of the issuance of this Note
or if the Registration Statement is not declared effective within 120 days of
the issuance of this Note (each such failure being referred to as an
"Registration Event"), the Maker shall pay as liquidated damages and not as a
penalty to the Holder an amount equal to 2% of the purchase price of the Note
for each 30-day period until the applicable Registration Event has been cured.
The amount of the liquidated damages shall be prorated on a daily basis for
periods less than 30 days. The liquidated damages shall be paid within five (5)
business days of the end of each month during which the Registration Event has
occurred and is continuing.

                     (c) In the event that the number of shares of Common Stock
qualified by the Registration Statement are less than the number of shares of
Common stock issuable to the Holder upon conversion of this Note, the Holder may
require the Company to register the additional shares of Common Stock (the
"Shortfall Shares") and the Company shall, as promptly as practicable thereafter
but in no event later than ninety (90) days after the Holder makes its request,
file another Registration Statement (the "Additional Registration Statement")
with the SEC to register the Shortfall Shares and to use its best efforts to
have the Additional Registration Statement declared effective within one hundred
twenty (120) days thereafter. If the Additional Registration Statement is not
filed within 90 days of the date of delivery of a notice requiring the

                                      -2-

<PAGE>

Company to register the Shortfall Shares as provided herein or if the Additional
Registration Statement is not declared effective within 120 days of date of such
notice (each such failure being referred to as an "Event"), the Company shall
pay as liquidated damages and not as a penalty to the Holder an amount equal to
2% of the purchase price of the Note for each 30-day period until the applicable
Event has been cured. The amount of the liquidated damages shall be prorated on
a daily basis for periods less than 30 days. The liquidated damages shall be
paid within five (5) business days of the end of each month during which the
Event has occurred and is continuing.

                     (d) The Maker shall not (i) pledge any of its assets,
including licenses, to any third party or (ii) incur indebtedness with ranks
pari passu or senior to this Note.

                  5. Events of Default. The occurrence at any time of any one or
more of the following events shall constitute an "Event of Default" under this
Note: (a) the Maker's failure to pay principal of, interest on or other amount
when due under this Note, which failure remains unremedied for a period of ten
(10) days after the date such payment is due from the Maker; (b) failure of the
Maker to perform or default in the observance by the Maker of any of the Maker's
agreements, covenants and/or obligations set forth herein or in any other
agreement to which the Maker and the Holder are parties, or a material breach of
any of Maker's representations and warranties set forth herein or in any other
agreement, and such nonperformance or default continues for a period of ten (10)
days after receipt by Maker of written notice thereof from the Holder; (c) the
dissolution, liquidation or termination of legal existence of the Maker; (d) the
appointment of a receiver, trustee or similar official or agent to take charge
of or liquidate any property of assets of the Maker, or action by any court to
take jurisdiction of all or a substantial portion of the property or assets of
the Maker; (e) the sale of all or substantially all of the Maker's property or
assets; (f) a judgment shall be entered against the Maker involving a liability
of $500,000 or more and such judgment shall remain undischarged for a period of
30 days during which execution shall not be effectively stayed or such judgment
is not covered by insurance; or (g) the commencement of any proceeding by the
Maker or any other party under any provision of the Bankruptcy Code of the
United States, as now in existence or hereafter amended, or of any other
proceeding under any applicable federal or state law, now existing or hereafter
in effect, relating to bankruptcy, reorganization, insolvency, liquidation or
otherwise, for the relief of debtors or readjustment of indebtedness, by or
against Maker; provided, that with respect to any proceeding commenced against
the Maker such proceeding remains undismissed or unstayed for a period of 30
days, or any of the actions sought in such proceedings occur.

                  6. Effect of Default. Upon the occurrence of an Event of
Default, the outstanding principal amount of this Note together with accrued
interest hereon and any other amounts owing by the Maker to the Holder under
this Note or otherwise shall, upon written notice from the Holder to the Maker,
become immediately due and payable without presentment, demand, protest or
notice, all of which are hereby expressly unconditionally and irrevocably waived
by the Maker.

                  7. Conversion.

                                      -3-

<PAGE>

                     (a) Upon the election of the Holder to convert this Note as
provided in Section 2 hereof, the Holder shall give written notice of such
election to the Maker. From the date hereof through the Maturity Date, the Maker
at its option may require the Holder to convert this Note; provided, that the
(x) registration statement referred to in Section 4(a) hereof has been effective
for ninety (90) consecutive days and the Common Stock has had a closing bid
price equal to or greater than US$ 4.00 for the five (5) consecutive trading
days preceding the delivery of the conversion notice and (y) no Event of Default
has occurred and is continuing. The outstanding principal amount of this Note
plus all accrued and unpaid interest herein shall be converted into the Maker's
Common Stock at the conversion price equal to the lesser of (i) US $4.00 or (ii)
80% of the average closing bid price of the Common Stock for the ten consecutive
trading days preceding the conversion date, as reported on Bloomberg L.P.

                     (b) In connection with any conversion of this Note in
accordance with this Section 7, the Holder shall deliver to the Maker the
original version of this Note to be converted marked "Canceled", and
acknowledged by the Holder to be paid-in-full in exchange for certificate(s)
representing the shares of Common Stock issued in the name of the Holder and
determined in accordance with Section 7(a) hereof. The Maker shall deliver the
certificate(s) representing the shares of Common Stock to the Holder within
three (3) business days' of its receipt of the original version of this Note.

                     (c) Notwithstanding anything herein contained, if upon the
election of the Holder to convert this Note to Common Stock, the Holder is
entitled to more than 500,000 shares of Common Stock, the Maker may satisfy its
obligations to the Holder by delivery of 500,000 shares of Common Stock at the
time set out in this Note and contemporaneously therewith delivering to the
Holder a certified check in an amount equal to the full amount of principal and
interest owing pursuant to this Note less a credit for the value represented by
the 500,000 shares of Common Stock delivered to the Holder calculated based on
the formula for valuation set out in subsection 7(a) hereof.

                  8. Transfer. Subject to the limitations set forth on the
legend on this Note, this Note may be transferred, sold, pledged, hypothecated
or otherwise granted as security by the Holder. The obligations of the Maker
hereunder may not be assigned. This Note shall inure to the benefit of the
transferees, successors and assigns of the Holder of this Note and shall be
binding upon the successors of the Maker.

                  9. Replacement. Upon receipt by the Maker of a duly executed,
notarized and unsecured written statement from the Holder with respect to the
loss, theft or destruction of this Note (or any replacement hereof), and without
requiring an indemnity bond or other security, or, in the case of a mutilation
of this Note, upon surrender and cancellation of such Note, the Maker shall
issue a new Note, of like tenor and amount, in lieu of such lost, stolen,
destroyed or mutilated Note.

                  10. No Fractional Securities. The Maker shall not issue
fractional shares of

                                      -4-
<PAGE>

Common Stock issued upon conversion of this Note, but in lieu of any such
fractional shares of Common Stock, the Maker shall make cash payment therefor
upon the basis of the fair market value of the Common Stock issued on the
Maturity Date or conversion date.

                  11. Additional Representations and Warranties. The Maker
hereby represents and warrants to the Holder that (a) the execution, delivery
and performance of this Note, the issuance of the Warrant and the transactions
contemplated hereby and thereby have been, and the issuance of Common Stock upon
conversion of this Note or upon exercise of the Warrant, will be, duly
authorized by the Maker in accordance with all applicable corporate power and
authority; (b) this Note has been duly executed by the Maker; (c) this Note is,
and the Warrant when issued will be, the legal, valid and binding obligations of
the Company enforceable against the Company in accordance with their respective
terms; (d) the execution, delivery and performance of this Note, the issuance of
the Warrant and the consummation of the transactions contemplated hereby and
thereby (i) do not violate or contravene the certificate of incorporation or
by-laws of the Maker or any order or judgment to which the Maker is a party or
otherwise bound; or (ii) create a default under, or cause a termination or
acceleration of, any agreement, contract or other instrument to which the Maker
is a party or otherwise bound; and (e) the Maker has no indebtedness for
borrowed money and has not granted a security interest to any third party on any
of its assets.

                  12. Expenses. The Maker agrees to pay all costs and expenses
(including, without limitation, attorneys' fees and expenses) incurred by the
Holder in connection with any action, suit or proceeding arising out of or
relating to this Note, the Warrant or any of the transactions contemplated
hereby or thereby related hereto.

                  13. Waivers, etc. Failure by the Holder to insist upon the
strict performance by the Maker of any terms and provisions herein shall not be
deemed to be a waiver of any terms and provisions herein, and the Holder shall
retain the right thereafter to insist upon strict performance by the Maker of
any and all terms and provisions of this Note or any document securing the
repayment of this Note. The Maker waives diligence, demand, presentment for
payment, notice of nonpayment, protest and notice of protest, and notice of any
renewals or extensions of this Note. This Note may not be amended, modified or
waived except by an instrument in writing signed by the Maker and the Holder.

                  14. Governing Law. (a) This Note shall be governed by and
construed in accordance with the laws of the State of New York, without regard
to its conflicts of laws principles. This Note shall be interpreted and
construed without any presumption against the Holder by virtue of the Holder
being the party to cause this Note to be drafted.

                     (b) Any legal action or proceeding with respect to this
Note, the Warrant or any of the transactions contemplated hereby and thereby may
be brought in the courts of the State of New York or of the United States of
America for the Southern District of New York, and, by execution and delivery of
this Note, the Maker hereby unconditionally and irrevocably consents to the
personal jurisdiction of the aforesaid courts for itself and in respect of its
property, generally and unconditionally. The Maker hereby unconditionally and
irrevocably waives, in connection with any such action or proceeding brought in
the aforesaid courts, any

                                      -5-
<PAGE>

objection, including, without limitation, any objection to the laying of venue
or based on the grounds of forum non conveniens, which they may now or hereafter
have to the bringing of any such action or proceeding in such courts, and the
right to seek and/or obtain a trial by jury.

                  15. Headings. Section headings in this Note are included
herein for purposes of convenience of reference only and shall not constitute a
part of this Note for any other purpose or taken into account in connection with
the construction or interpretation of this Note.

                  IN WITNESS WHEREOF, the Maker has executed this Note as of the
date specified above.

                                                 TRINITY MEDICAL GROUP USA, INC.

                                                 By: /s/ James Namnath
                                                   -----------------------------
                                                   Name: James Namnath
                                                   Title: CEP

                                      -6-
<PAGE>
                                  ATTACHMENT A
                                  ------------

THE SALE AND ISSUANCE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE  "SECURITIES
ACT"), OR UNDER THE SECURITIES LAW OF ANY STATE OR OTHER  JURISDICTION.  NEITHER
THIS  SECURITY NOR ANY INTEREST OR  PARTICIPATION  HEREIN MAY BE OFFERED,  SOLD,
ASSIGNED, TRANSFERRED,  PLEDGED, ENCUMBERED,  HYPOTHECATED OR OTHERWISE DISPOSED
OF, UNLESS PURSUANT TO AN EFFECTIVE  REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO A  TRANSACTION  THAT IS EXEMPT FROM,  OR NOT SUBJECT TO, SUCH
REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS.

                         TRINITY MEDICAL GROUP USA, INC.

                          COMMON STOCK PURCHASE WARRANT

         1. Issuance. In consideration of good and valuable  consideration,  the
receipt of which is hereby  acknowledged  by Trinity  Medical Group USA, Inc., a
Florida  corporation  (the  "Company"),  Roycap Inc.  (the  "Holder")  is hereby
granted the right to  purchase at any time until 5:00 P.M.,  New York City time,
on [5 years from conversion date] (the "Expiration Date"), ___________ shares of
the  Company's  Common  Stock,  par value $.001 per share (the  "Shares")  at an
initial exercise price of $4.00 per share (the "Exercise Price").

         2.  Exercise of Warrants.  This Warrant is  exercisable  in whole or in
part at the Exercise Price per share of Common Stock payable hereunder,  payable
in cash or by certified or official bank check.  Upon  surrender of this Warrant
Certificate  with the annexed  Notice of Exercise Form duly  executed,  together
with payment of the Exercise Price for the shares of Common Stock purchased, the
Holder shall be entitled to receive a certificate or certificates for the shares
of Common Stock so purchased.

         3.  Reservation of Shares.  The Company hereby agrees that at all times
during the term of this  Warrant  there  shall be  reserved  for  issuance  upon
exercise of this  Warrant  such number of shares of its Common Stock as shall be
required for issuance upon exercise of this Warrant (the "Warrant Shares").

         4.  Mutilation  or Loss of  Warrant.  Upon  receipt  by the  Company of
evidence  satisfactory  to it of the loss,  theft,  destruction or mutilation of
this  Warrant,  and (in the  case of  loss,  theft or  destruction)  receipt  of
reasonably  satisfactory  indemnification,  and (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will execute and deliver
a new  Warrant of like tenor and date and any such lost,  stolen,  destroyed  or
mutilated Warrant shall thereupon become void.

         5. Rights of the Holder.  This Warrant is being issued to the Holder in
connection with a Subscription  Agreement dated October 19, 2000 from the Holder
to the Company and a Convertible  Promissory  Note,  dated October 19, 2000 (the
"Note") issued by the

<PAGE>

Company to the order of the Holder in the principal amount
of $500,000.  The Holder shall not, by virtue hereof,  be entitled to any rights
of a stockholder in the Company,  either at law or equity, and the rights of the
Holder are limited to those  expressed in this  Warrant and are not  enforceable
against the Company except to the extent set forth herein.

         6. Transfer to Comply with the Securities Act; Registration Rights.

            (a) This Warrant has not been registered under the Securities Act of
1933,  as amended  (the "Act") and has been issued to the Holder for  investment
and not with a view to the  distribution  of either the  Warrant or the  Warrant
Shares. Neither this Warrant nor any of the Warrant Shares or any other security
issued or  issuable  upon  exercise of this  Warrant  may be sold,  transferred,
pledged or  hypothecated in the absence of an effective  registration  statement
under the Act relating to such security or an opinion of counsel satisfactory to
the Company that  registration  is not required under the Act. Each  certificate
for the Warrant,  the Warrant Shares and any other  security  issued or issuable
upon exercise of this Warrant  shall  contain a legend on the face  thereof,  in
form and substance  satisfactory  to counsel for the Company,  setting forth the
restrictions on transfer contained in this Section.

            (b) The Company hereby grants to the Holder  piggyback  registration
rights with respect to the Warrant  Shares.  The Company  agrees to register the
Warrant  Shares within one hundred  twenty (120) days after the issuance of this
Warrant.  The  Company  shall  keep  the  registration   statement  continuously
effective  through November 19, 2001, and shall cause the related  prospectus to
be amended or supplemented by a required prospectus  supplement pursuant to Rule
424 under the Act. If the registration  statement is not filed within 30 days of
the  date of  issuance  of the  Note  or if the  registration  statement  is not
declared  effective  within  120 days of the  issuance  of the Note  (each  such
failure  being  referred to as an "Event"),  the Company shall pay as liquidated
damages and not as a penalty to the Holder an amount equal to 2% of the purchase
price of the Note for each 30-day  period  until the  applicable  Event has been
cured.  The amount of the liquidated  damages shall be prorated on a daily basis
for periods less than 30 days. The liquidated  damages shall be paid within five
(5)  business  days of the end of each month during which the Event has occurred
and is continuing.

            (c) Commencing on November 19, 2001 through the Expiration  Date and
so long as this Warrant remains outstanding,  the Holder may require the Company
to  register  the  Warrant  Shares,  and  the  Company  shall,  as  promptly  as
practicable  thereafter  but in no event  later than  ninety (90) days after the
Holder makes its request, file a registration  statement with the Securities and
Exchange  Commission to register the Warrant  Shares and to use its best efforts
to have such registration statement declared effective within one hundred twenty
(120) days thereafter. If the registration statement is not filed within 90 days
of the date of  delivery  of a notice  requiring  the  Company to  register  the
Warrant  Shares as  provided  herein  or if the  registration  statement  is not
declared  effective  within 120 days of date of such notice  (each such  failure
being  referred to as an "Event"),  the Company shall pay as liquidated  damages
and not as a penalty to the Holder an amount equal to 1% of the  purchase  price
of the Note for each 30-day  period until the  applicable  Event has been cured.
The amount of the  liquidated  damages  shall be  prorated  on a daily basis for
periods less than 30 days. The liquidated  damages shall be paid within five (5)
business  days of the end of each month  during which the Event has occurred and

                                      -2-

<PAGE>

is continuing.  The Company shall keep the registration  statement  continuously
effective  until the  earlier of (i) the date the  Holder has owned the  Warrant
Shares for one (1) year and (ii) thirty (30) days after the Expiration Date. The
Company shall keep the registration  statement  continuously effective until the
earlier of (i) the date the Holder has owned the Warrant Shares for one (1) year
and (ii) thirty (30) days after the Expiration Date.

            (d)  Provided  that a  registration  statement  with  respect to the
Warrant Shares is effective at the time notice pursuant to this subsection 6 (b)
is given to the Holder, the Company may upon five (5) days written notice to the
Holder  call this  Warrant  (the "Call  Notice")  at the  Exercise  Price if the
Company's  Common  Stock has traded at a closing  bid price  equal to or greater
than $12.00 per share for five (5)  consecutive  trading  days prior to the date
the Company calls this Warrant.  The rights and privileges  granted  pursuant to
this Warrant shall  terminate  thirty (30) days after the Call Notice is sent to
the Holder if this Warrant is not  exercised  during that  period.  In the event
this Warrant is not exercised during this thirty-day period,  this Warrant shall
expire.

         7.  Notices.  Any notice or other  communication  required or permitted
hereunder  shall be in writing and shall be delivered  personally,  telegraphed,
telexed,  sent by facsimile  transmission  or sent by  certified,  registered or
express mail,  postage  pre-paid.  Any such notice shall be deemed given when so
delivered personally,  telegraphed,  telexed or sent by facsimile  transmission,
or, if mailed, two days after the date of deposit in the United States mails, as
follows:

(1)      if to the Company, to:

                                    Trinity Medical Group USA, Inc.
                                    55 Shaver Street, Suite 320
                                    San Rafael, California 94901
                                    Attn: Chief Financial Officer

(2)      if to the Holder, to:

                                    RoyCap Inc.
                                    4100 Yonge Street
                                    Suite 504
                                    Toronto, Ontario M2P 2G2
                                    Attn:  Stephen Rider

Any party may be  notice  given in  accordance  with this  Section  to the other
parties designate another address or person for receipt of notices hereunder.

         8.  Supplements and Amendments;  Whole  Agreement.  This Warrant may be
amended or  supplemented  only by an instrument in writing signed by the parties
hereto. This Warrant of even date herewith contain the full understanding of the
parties  hereto with respect to the subject  matter hereof and thereof and there
are no  representations,  warranties,  agreements or  understandings  other than
expressly contained herein and therein.

                                      -3-
<PAGE>

         9.  Governing  Law.  This Warrant shall be deemed to be a contract made
under the laws of the State of New York and for all  purposes  shall be governed
by and  construed  in  accordance  with the  laws of such  State  applicable  to
contracts to be made and performed entirely within such State.

         10.  Counterparts.  This  Warrant  may be  executed  in any  number  of
counterparts and each of such  counterparts  shall for all purposes be deemed to
be an original,  and all such counterparts shall together constitute but one and
the same instrument.

         11. Descriptive Headings.  Descriptive headings of the several Sections
of this  Warrant  are  inserted  for  convenience  only and shall not control or
affect the meaning or construction of any of the provisions hereof.

         IN WITNESS WHEREOF, the parties hereto have executed this Warrant as of
the 19th day of October, 2000.

                                                 TRINITY MEDICAL GROUP USA, INC.

                                      By: /s/ James S. Namnath
                                         ---------------------------------------
                                          Name:  James S. Namnath
                                          Title: CEO

                                      -4-

<PAGE>

                          NOTICE OF EXERCISE OF WARRANT

         The Holder hereby irrevocably elects to exercise the right, represented
by the Warrant  Certificate  dated as of __________,  2000, to purchase  _______
shares of the Common Stock,  par value $4.00 per share, of Trinity Medical Group
USA,  Inc. and tenders  herewith  payment in  accordance  with Section 1 of said
Common Stock Purchase Warrant.

         Please deliver the stock certificate to:

         -----------------------------

Dated:______________________

                                                    By: _______________________
                                                    Name:  ____________________
                                                    Title: ____________________

                                      -5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}]]